{
	"kihkd3aiText": "69<span class=\"_ _6\"></span>%<span class=\"_ _6\"></span><span class=\"fs2 ls0 ws0\"> <span class=\"fc0 ls14 ws1c\">patient<span class=\"_ _4\"></span>s achiev<span class=\"_ _1\"></span>ed remi<span class=\"_ _4\"></span>ssion at week 1<span class=\"_ _2\"></span>2<span class=\"_\"> </span> </span></span>",
	"kihkd3ajText": "with<span class=\"_\"> </span> Brintellix<span class=\"_ _1\"></span>®<span class=\"_ _1\"></span><span class=\"fs3 ls0 v1\">2</span>",
	"kihkd3akText": "Study Design",
	"kihkd3alText": "MADRS total mean scores<span class=\"fsb v2\">1,2</span>",
	"kihkd3amText": "Remission defined as MADRS total score ≤10 a<span class=\"_ _1\"></span>t weeks 10 and 12",
	"kihkd3anText": "Brintellix® in<span class=\"_ _4\"></span> ",
	"kihkd3aoText": "relapse prevention",
	"kihkd3apText": "S<span class=\"_ _4\"></span>TA<span class=\"_ _6\"></span>R<span class=\"_ _4\"></span>*<span class=\"_ _4\"></span>D",
	"kihkd3aqText": "Mean MADRS total score<span class=\"fs20 v7\">¶</span>",
	"kihkd3arText": "¶<span class=\"fs10 ws0 v8\">Based on observed cases analysis of the all patients treated set population; MADRS=Montgomery <span class=\"_ _0\"></span>Åsberg Depression R<span class=\"_ _0\"></span>ating Scale</span>",
	"kihkd3asText": "Brintellix® 5 or 10 mg /day (n=639)",
	"kihkd3atText": "Approximately 75% of patients <br>wer<span class=\"_ _0\"></span>e taking 10 mg/day at <br>week 12",
	"kihkd3auText": "W<span class=\"_ _0\"></span>eek",
	"kihkd3avText": "Score impr<span class=\"_ _0\"></span>ovement",
	"Brintellix_22f629d07c": "<span style=\"color: rgb(77, 127, 134); font-family: '15_VDWFON+AvenirNextLTPro-Demi';\"><font style=\"font-size: 25px;\">References</font></span>",
	"Brintellix_2284ab5ebd": "<font style=\"font-size: 15px; font-family: '2_VDWFON+AvenirNextLTPro-Demi'; color: rgb(100, 94, 94);\"><b>1.</b></font><div><font style=\"font-size: 15px; font-family: '2_VDWFON+AvenirNextLTPro-Demi'; color: rgb(100, 94, 94);\"><b>2.</b></font></div>",
	"Brintellix_22191feb4c": "<font style=\"font-size: 15px; font-family: '3_BNJCUB+AvenirNextLTPro-Regular';color: rgb(100, 94, 94);\">Data on file. 2013 Takeda Pharmaceuticals.\n<br>Boulenger JP et al. J Psychopharmacol 2012;26:1408-1416.</font>",
	"Brintellix_228e5d7cb1": "",
	"Brintellix_225f8383a8": "",
	"Brintellix_221f7956fe": "Text",
	"Brintellix_2201352e84": "Text",
	"Brintellix_22a522ec1b": "Text",
	"Brintellix_2263952095": "Text",
	"Brintellix_2286ff6508": "Text",
	"Brintellix_22683c22e4": "Text",
	"Brintellix_2224a6d710": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;background-color: #e5f0f2;box-sizing: border-box;color: #4d7f86;\">\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">MADRS 10</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">Physical symptoms</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;color: #fff;background: rgb(233,90,0);background: linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);background: -webkit-linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);\">Remission</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">Relapse prevention</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">Short term</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">Long term</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 12px 17px;line-height:1.3;background-color: #e5f0f2;\">Meta-analysis</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4px 12px 3px;line-height:1.3;background-color: #e5f0f2;\">Suboptimal responses<br>to SSRI/SNRI</div>\n</div>",
	"Brintellix_22542dd2f8": "Text"
}
